Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving certain combinations of
chemotherapy drugs before and after surgery, mostly in the outpatient clinic instead of in
the hospital, can result in fewer hospital stays during treatment for osteosarcoma. The drugs
and schedules will vary depending on the status of the cancer and its level of risk for
spreading, but they will include combinations of doxorubicin (non-liposomal), cisplatin,
methotrexate, and ifosfamide, as described below.